Product Code: ETC4469556 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The preclinical imaging market in Australia is growing as advancements in imaging technologies drive research in drug development and disease diagnostics. AI-powered imaging modalities such as MRI, PET, and CT scans are enhancing non-invasive studies, allowing researchers to gain deeper insights into biological processes and treatment efficacy before clinical trials.
The preclinical imaging market in Australia is growing due to increasing demand for drug development and biomedical research. Rising adoption of preclinical imaging systems for studying disease progression and drug efficacy is driving market growth. Enhanced focus on improving imaging resolution, multi-modal capabilities, and data analysis is supporting market performance.
The preclinical imaging market in Australia faces challenges from high costs of imaging equipment and regulatory hurdles in clinical trials. Technical difficulties in ensuring high-resolution imaging and data management issues further restrict market growth.
The Australia Preclinical Imaging Market presents significant growth opportunities due to increasing investments in drug development and medical research. Investment opportunities include developing AI-powered imaging systems, enhancing image resolution, and expanding into pharmaceutical and biotechnology research.
Preclinical imaging systems used for drug development and research are regulated under the Therapeutic Goods Act 1989 and the Australian Code for the Care and Use of Animals for Scientific Purposes. The government mandates that imaging systems used in animal testing meet ethical and safety guidelines set by the National Health and Medical Research Council (NHMRC).
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Preclinical Imaging Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Preclinical Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Preclinical Imaging Market - Industry Life Cycle |
3.4 Australia Preclinical Imaging Market - Porter's Five Forces |
3.5 Australia Preclinical Imaging Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Preclinical Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Preclinical Imaging Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Australia Preclinical Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in pharmaceutical and biotechnology industries |
4.2.2 Growing demand for non-invasive imaging techniques in preclinical research |
4.2.3 Technological advancements in imaging modalities leading to higher efficiency and accuracy |
4.3 Market Restraints |
4.3.1 High cost associated with preclinical imaging equipment and procedures |
4.3.2 Limited availability of skilled professionals in the field of preclinical imaging |
4.3.3 Stringent regulatory requirements for preclinical imaging studies |
5 Australia Preclinical Imaging Market Trends |
6 Australia Preclinical Imaging Market, By Types |
6.1 Australia Preclinical Imaging Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Preclinical Imaging Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Australia Preclinical Imaging Market Revenues & Volume, By CT Imaging, 2021-2031F |
6.1.4 Australia Preclinical Imaging Market Revenues & Volume, By MRI Imaging, 2021-2031F |
6.1.5 Australia Preclinical Imaging Market Revenues & Volume, By PET/SPECT Imaging, 2021-2031F |
6.1.6 Australia Preclinical Imaging Market Revenues & Volume, By Multi-modal Imaging, 2021-2031F |
6.1.7 Australia Preclinical Imaging Market Revenues & Volume, By Optical Imaging, 2021-2031F |
6.1.8 Australia Preclinical Imaging Market Revenues & Volume, By Ultrasound Imaging, 2021-2031F |
6.1.9 Australia Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.1.10 Australia Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.2 Australia Preclinical Imaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Preclinical Imaging Market Revenues & Volume, By Research and Development, 2021-2031F |
6.2.3 Australia Preclinical Imaging Market Revenues & Volume, By Drug Discovery, 2021-2031F |
6.3 Australia Preclinical Imaging Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Australia Preclinical Imaging Market Revenues & Volume, By Biotech Companies, 2021-2031F |
6.3.3 Australia Preclinical Imaging Market Revenues & Volume, By Pharmaceutical companies, 2021-2031F |
6.3.4 Australia Preclinical Imaging Market Revenues & Volume, By Research institutes, 2021-2031F |
7 Australia Preclinical Imaging Market Import-Export Trade Statistics |
7.1 Australia Preclinical Imaging Market Export to Major Countries |
7.2 Australia Preclinical Imaging Market Imports from Major Countries |
8 Australia Preclinical Imaging Market Key Performance Indicators |
8.1 Number of research collaborations between academic institutions and industry players for preclinical imaging |
8.2 Adoption rate of novel preclinical imaging technologies in Australia |
8.3 Growth in government funding for preclinical imaging research |
8.4 Rate of publications and citations related to preclinical imaging studies |
8.5 Investment trends in preclinical imaging startups in Australia |
9 Australia Preclinical Imaging Market - Opportunity Assessment |
9.1 Australia Preclinical Imaging Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Preclinical Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Preclinical Imaging Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Australia Preclinical Imaging Market - Competitive Landscape |
10.1 Australia Preclinical Imaging Market Revenue Share, By Companies, 2024 |
10.2 Australia Preclinical Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |